Long-term blood pressure variability and development of chronic kidney disease in type 2 diabetes. in Journal of hypertension / J Hypertens. 2019 Apr;37(4):805-813. doi: 10.1097/HJH.0000000000001950.
2019
ASL Torino 5
Tipo pubblicazione
Research Support, Non-U.S. Gov't
Autori/Collaboratori (10)Vedi tutti...
Viazzi F
Università degli Studi and Policlinico San Martino-IST, Genova.
Bonino B
Università degli Studi and Policlinico San Martino-IST, Genova.
Mirijello A
Department of Medical Sciences, Scientific Institute 'Casa Sollievo della Sofferenza', San Giovanni Rotondo, Foggia.
et alii...
Abstract
OBJECTIVE: Long-term visit-to-visit SBP variability (VVV) has been shown to predict cerebro-cardiovascular events and end-stage renal disease in chronic kidney disease (CKD) patients. Whether SBP VVV is also a predictor of CKD development in diabetes is currently uncertain. We assessed the role of SBP VVV on the development of CKD in patients with type 2 diabetes (T2D) and hypertension in real life. METHODS: Clinical records from 30?851 patients with T2D and hypertension, with normal estimated glomerular filtration rate (eGFR) and regular visits during a 4-year follow-up were analyzed. SBP variability was measured by three metrics: coefficient of variation; SD of the mean SBP and average absolute difference of successive values in each individual. CKD was defined as eGFR less than 60 and/or a reduction in eGFR at least 30% from baseline. RESULTS: Over the 4-year follow-up, 9.7% developed eGFR less than 60 and 4.5% an eGFR reduction at least 30% from baseline. Several clinical characteristics (older age, male sex, SBP, DBP, albuminuria, glycated hemoglobin, insulin treatment) were related to intraindividual SBP variability. Patients with VVV in the upper quintile showed an increased risk of developing both components of CKD [adjusted odds ratio (OR) 1.21, P?
Accesso banca dati bibliografica
Accedi alla scheda bibliografica del documento in PUBMED
PMID : 30817462
DOI : 10.1097/HJH.0000000000001950
Keywords
estimated glomerular filtration rate; end stage renal disease; diastolic blood pressure; cohort analysis; blood pressure variability; chronic kidney failure; article; albuminuria; age; aged; adult; insulin; oral antidiabetic agent; hemoglobin A1c; antihypertensive agent; human; gender; follow up; female; hypertension; incidence; insulin treatment; major clinical study; male; middle aged; non insulin dependent diabetes mellitus; predictive value; priority journal; systolic blood pressure;